2024
DOI: 10.1007/s12602-024-10267-7
|View full text |Cite
|
Sign up to set email alerts
|

An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD)

Lingshuang Yang,
Yuwei Wu,
Xinyu Zhao
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 51 publications
0
0
0
Order By: Relevance
“…For patients with diarrhoea-predominant irritable bowel syndrome (IBS-D), a reduction in the levels of pro-inflammatory cytokines, and intestinal permeability as well as an improvement in gastrointestinal symptoms were observed after treating with B. longum ES1 for 8 or 12 weeks 43 . B. longum L556, isolated from healthy human feces, enhanced anti-inflammatory effects by modulating gut microbiota and metabolites like SCFAs, ultimately regulated lipid and amino acid metabolism in coronary heart disease group 44 .…”
Section: Discussionmentioning
confidence: 99%
“…For patients with diarrhoea-predominant irritable bowel syndrome (IBS-D), a reduction in the levels of pro-inflammatory cytokines, and intestinal permeability as well as an improvement in gastrointestinal symptoms were observed after treating with B. longum ES1 for 8 or 12 weeks 43 . B. longum L556, isolated from healthy human feces, enhanced anti-inflammatory effects by modulating gut microbiota and metabolites like SCFAs, ultimately regulated lipid and amino acid metabolism in coronary heart disease group 44 .…”
Section: Discussionmentioning
confidence: 99%